Assam International Northeast

Bangladesh signs agreement with Serum Institute of India for procuring Covid-19 vaccine

On Sunday, the government of Bangladesh signed an agreement with the Serum Institute of India (SII) for procurement of 3 crore doses of the Oxford/ Astrazeneca vaccine. The vaccine will be delivered in six installments of 50 lakh doses each.

Health Minister Zahed Maleq said after the signing of the agreement that the vaccine has proved safe during trials in different countries and it is suitable for Bangladesh, as per the reports of the news agency UNB. He said the government is also in talks with other countries to procure more doses of the COVID-19 vaccine.

Earlier, on November 15, a tripartite MoU was signed between SII, Bangladesh pharmaceutical company Beximco Pharmaceuticals Ltd (BPL) and the government of Bangladesh for the procurement of the Oxford/Astrazeneca COVID-19 vaccine.

Meanwhile, Bangladesh reported 32 more deaths due to Coronavirus on Sunday taking the death toll to 7,052.

According to the latest figures released by the Directorate General of Health Services (DGHS), 1,355 new cases and 3,393 recoveries were also reported over the last 24 hours.

Total number of people infected by Coronavirus in Bangladesh now stands at 4.9 lakh. Recovery rate in the country is 85.80 per cent.

About the author

Team News Move

Leave a Comment